Brain Radiation After Lung Cancer Tre...

Brain Radiation After Lung Cancer Treatment Reduces Risk Of Cancer Spreading

There are 1 comment on the MediLexicon story from Sep 10, 2012, titled Brain Radiation After Lung Cancer Treatment Reduces Risk Of Cancer Spreading. In it, MediLexicon reports that:

Stage III non-small cell lung cancer patients treated with surgery and/or radiation therapy have a significantly reduced risk of developing brain metastases if they also receive prophylactic cranial irradiation ; however, this study did not show an improvement in overall survival with PCI, according to research presented at the 2012 Chicago ... (more)

Join the discussion below, or Read more at MediLexicon.

Since: Dec 05

Reading, PA

#1 Sep 10, 2012
Prophylactic Cranial Irradiation Fails to Improve NSCLC Survival

PCI did not improve overall survival in a randomized trial of 340 patients in this study. Movsas, et al study of PCI vs Observation in Patients with Stage III NSCLC (ASTRO 2009) found that there was no significant impact on quality of life, patients who underwent PCI had a greater decline in immediate memory recall and delayed memory recall than patients who did not have PCI.

According to Movsas, these findings offer a more complete perspective regarding this intervention for patients with NSCLC. So in regards to NSCLC, there is no proven value of PCI for NSCLC. Whether NSCLC or SCLC, if they prophylactically irradiated just the whole brain but not the spinal cord, how does it benefit the patient? Any "theoretical" cancer cells in the spinal cord would eventually infiltrate the brain.

And it is likely that the true incidence of treatment-related side effects of cranial irradiation in adults who survive more than six months without brain tumor growth or recurrence has been significantly underestimated.

The question of whether systemic therapies can be as effective as PCI with a more favorable side effect profile is an interesting one, and one that might have more value with agents like tyrosine kinase inhibitors like Iressa and Tarceva against brain metastases. The poor survival of leptomeningeal metastases by PCI highlights the importance of treating lung cancer patients with TKIs on outcomes.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Oncology Discussions

Title Updated Last By Comments
News Biden Hosting Cancer Summit to Try to Accelerat... Wed Unsolicited Advice 2
News Biden hosting cancer summit to try to accelerat... Jun 29 Le Jimbo 1
News Racially biased cancer doctors spend less time ... Jun 25 Summer Friend 6
Thoughts on new CMS rules for billing on ambula... Jun 9 Novice 1
News Long-term outcomes in radically treated synchro... Jun 2 why use BIG words 1
News Screening for breast and cervical cancer is a p... May '16 Three Days 5K 1
News Not just pets: Dogs, cats may show way to bette... May '16 Dumb Animals 2
More from around the web